Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study).

Ducreux M, Adenis A, Pignon JP, François E, Chauffert B, Ichanté JL, Boucher E, Ychou M, Pierga JY, Montoto-Grillot C, Conroy T.

Eur J Cancer. 2013 Apr;49(6):1236-45. doi: 10.1016/j.ejca.2012.12.011. Epub 2013 Jan 24.

PMID:
23352604
2.

Two direct targets of cytokinin signaling regulate symbiotic nodulation in Medicago truncatula.

Ariel F, Brault-Hernandez M, Laffont C, Huault E, Brault M, Plet J, Moison M, Blanchet S, Ichanté JL, Chabaud M, Carrere S, Crespi M, Chan RL, Frugier F.

Plant Cell. 2012 Sep;24(9):3838-52. doi: 10.1105/tpc.112.103267. Epub 2012 Sep 28.

3.

Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma--a report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE).

Minard-Colin V, Ichante JL, Nguyen L, Paci A, Orbach D, Bergeron C, Defachelles AS, André N, Corradini N, Schmitt C, Tabone MD, Blouin P, Sirvent N, Goma G, Geoerger B, Oberlin O.

Eur J Cancer. 2012 Oct;48(15):2409-16. doi: 10.1016/j.ejca.2012.04.012. Epub 2012 May 25.

PMID:
22633624
4.

Comparative transcriptomic analysis of salt adaptation in roots of contrasting Medicago truncatula genotypes.

Zahaf O, Blanchet S, de Zélicourt A, Alunni B, Plet J, Laffont C, de Lorenzo L, Imbeaud S, Ichanté JL, Diet A, Badri M, Zabalza A, González EM, Delacroix H, Gruber V, Frugier F, Crespi M.

Mol Plant. 2012 Sep;5(5):1068-81. doi: 10.1093/mp/sss009. Epub 2012 Mar 14.

5.

Factors associated with altered long-term well-being after prophylactic salpingo-oophorectomy among women at increased hereditary risk for breast and ovarian cancer.

Touboul C, Uzan C, Ichanté JL, Caron O, Dunant A, Dauchy S, Gouy S, de Paillerets BB, Morice P, Delaloge S.

Oncologist. 2011;16(9):1250-7. doi: 10.1634/theoncologist.2010-0336. Epub 2011 Jul 17.

6.

MAnGO: an interactive R-based tool for two-colour microarray analysis.

Marisa L, Ichanté JL, Reymond N, Aggerbeck L, Delacroix H, Mucchielli-Giorgi MH.

Bioinformatics. 2007 Sep 1;23(17):2339-41. Epub 2007 Jun 22.

PMID:
17586547
7.

Molecular profile of mouse stromal mesenchymal stem cells.

Chateauvieux S, Ichanté JL, Delorme B, Frouin V, Piétu G, Langonné A, Gallay N, Sensebé L, Martin MT, Moore KA, Charbord P.

Physiol Genomics. 2007 Apr 24;29(2):128-38. Epub 2006 Dec 19.

PMID:
17179208

Supplemental Content

Loading ...
Support Center